SHIZUKA AKIEDA

Cyfuse

At Kyushu University Hospital, I was engaged in research in the fields of genetics and regenerative medicine. Following this, I worked on a commercialization verification project under the Japan Science and Technology Agency (JST) of the Ministry of Education, Culture, Sports, Science and Technology, and in 2010, I founded Cyfuse Biomedical K.K., a venture from Kyushu University. I have participated in several projects with public institutions, including those by the Japan Agency for Medical Research and Development (AMED) and the New Energy and Industrial Technology Development Organization (NEDO). In addition to overseeing internal and external projects cross-functionally, I have been involved in managing a biotech venture, which continues to this day. Recently, in partnership with other companies, I succeeded in the world’s first clinical trial using a developed bio 3D printer for regenerative medicine products, advancing efforts to establish a business foundation in this field and developing a partnership strategy. In December 2022, the company was listed on the Tokyo Stock Exchange Growth Market. As a newly listed startup, we are committed to creating markets and industries in advanced medical fields through the development of Japan-originated and world-first products, contributing to society globally with Japan Quality manufacturing.

I have received several awards, including the JST University-initiated Venture Award, the Cabinet Office's Industry-Academia-Government Collaboration Award, and the Japan Venture Awards. I serve as a director of the Japan Bioindustry Association and a member of the International Committee of the Japanese Society for Regenerative Medicine.